tirzepatide court decision The FDA says the Zepbound shortage is over. That's rattling the weight loss industry FDA's tirzepatide decision creates uncertainty

For subscribers: The 2026 tournament has the highest rate of goals per match in decades

Whole-patient approach GLP-1 is one part of a comprehensive plan that may include nutrition, exercise, and management of related conditions

You cannot legally purchase BPC-157 for human use without a prescription

Our medical weight loss programs are ideal for individuals who have struggled to lose weight on their own or have: A body mass index (BMI) of 30 or higher (obese) A BMI of 27 or higher (overweight) with a weight-related health condition, such as type 2 diabetes, sleep apnea, or high blood pressure

Mass spectrometry has become one of the most powerful tools for peptide therapeutic characterization because it enables highly sensitive identification of molecular variants, degradation pathways, sequence modifications, and process-related impurities

Today, we have announced we have completed our business combination with Andretti Acquisition Corp